tweetindex
ES

Amanpour and Company

@AmanpourCoPBS · Global · joined 27 Jul 2018

#AmanpourPBS examines global and domestic news with @amanpour and contributors. Weeknights on @PBS-check local listings. 212-560-2888. programming@thirteen.org

28 232Followers
2 338Following
7 115Posts total
61.8KViews on collected posts

Últimas publicaciones

@AmanpourCoPBS @EricTopol @WalterIsaacson Your show has become the Middle East Pain Hour. There are other things going on in the world 10 views · 0 likes · 0 reposts · 0 replies Open on X →
@AmanpourCoPBS @EricTopol @WalterIsaacson GLP-1s don’t just reduce appetite—they mimic a prolonged fast. And yes, that can clear junk proteins… but it also shifts water structure, redox balance, and even astrocyte hydration states. I’m seeing the short-term benefits. But the lon 64 views · 1 likes · 0 reposts · 1 replies Open on X →
@AmanpourCoPBS @EricTopol @WalterIsaacson p-tau217 isn’t a static number—it’s a dynamic spike. @EricTopol’s GLP-1 vision is promising, but it’s still 2D thinking. With SpikeWatch + Spike-to-pTau217, we track, predict, and flatten the curve—in real time. This is 3D medicine, not s 108 views · 1 likes · 0 reposts · 0 replies Open on X →
Dr. Eric Topol shares his science-backed approach to achieving longevity and becoming a "Super Ager." @EricTopol @WalterIsaacson https://t.co/lskZat7zQF 33.7K views · 56 likes · 10 reposts · 26 replies Open on X →
Could GLP-1 drugs be used to fight Alzheimer's disease? Dr. Eric Topol, author of “Super Agers,” explains the possibilities. @EricTopol @WalterIsaacson https://t.co/9qGfNKGCTg
2:12
22K views · 141 likes · 39 reposts · 25 replies Open on X →
Jeff Bieber, co-director of the new PBS documentary “Hannah Arendt: Facing Tyranny,” explains the origins behind the phrase she coined, “the banality of evil.” @MichelMcQMartin https://t.co/7Wl2mikLrM
2:14
1.9K views · 20 likes · 13 reposts · 14 replies Open on X →
Will Governor Andy Beshear (D-KY) run for President? @GovAndyBeshear @MichelMcQMartin https://t.co/FO2fu6wAbu
1:18
1.4K views · 15 likes · 7 reposts · 12 replies Open on X →
2.7K views · 0 likes · 0 reposts · 0 replies Open on X →

Frente a cuentas del mismo tamaño

1 publicaciones de los últimos 90 días, junto al rango de 10K–100K seguidores. llega a menos gente que cuentas de su tamaño.

Visualizaciones medianas10esta cuenta1 041mediana de 10K–100K
Alcance, %0.04%esta cuenta3.78%mediana de 10K–100K
Interacción, %0.00%esta cuenta1.69%mediana de 10K–100K
MétricaEsta cuentaMediana de 10K–100KProporción
Visualizaciones medianas por publicación101 0410.01×
Alcance (visualizaciones ÷ seguidores)0.04%3.78%0.01×
Tasa de interacción0.00%1.69%0.00×

Otras cuentas de este rango →   Comparar con otra cuenta →   Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2.7K
1.4K9 Jul
1.9K10 Jul
22K11 Jul
33.7K
10812 Jul
64
109 Jul

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.00%
2.73%9 Jul
2.44%10 Jul
0.97%11 Jul
0.28%
0.93%12 Jul
3.12%
0.00%9 Jul

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.69%.

What the audience does

Likes48.3%234 in total
Reposts14.3%69 in total
Replies16.1%78 in total
Quotes2.9%14 in total
Bookmarks18.4%89 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Cuentas similares